Review Article

Heart-Kidney Interaction: Epidemiology of Cardiorenal Syndromes

Table 2

Summary of studies fulfilling criteria for Acute Cardiorenal Syndrome (CRS Type 1) with a presenting diagnosis of acute coronary syndrome.

StudyPopulation (n)Study type (data source)AKI (WRF) definitionIncidence AKI (%)Cardiac diseaseOutcome

Newsome et al., 2008 [12]n = 87,094
Mean Age 77 yrs
Male 50%
DM 28%–37%
Retrospective (CCP)VariableAny 43.2 ∆SCr Quartiles:
Q1: ∆0.1, 13.1;
Q2:∆0.2, 9.3;
Q3: ∆0.3–0.5, 12.3;
Q4: ∆0.6–3.0, 8.4
AMI Prevalence:
Prior MI 31%–35%
Prior HF 21%–35%
All-cause (death (1000 p-y)/HR):
Q1 146/1.1; Q2 157/1.2;
Q3 194/1.3; Q4 275/1.4
ESKD (incidence (1000 p-y)/HR):
Q1 2.3/1.5; Q2 3.6/2.0;
Q3 6.3/2.4; Q4 20/3.3
Parikh et al., 2008 [13]n = 147,007
Age 76–78 yrs
Male 49%-50%
DM 29%–41%
Retrospective (CCP)∆SCr (μmol/L):
Mild (26.5–35.4);
Mod (44.2–88.4);
Severe (≥88.4)
Any 19.4, Mild 7.1, Mod 7.1, Severe 5.2AMI Prevalence:
Prior AMI 30%–36%
Prior HF 19%–35%
All-cause (10 yr) (death (crude%)/adj-HR):
None 68/1.00; Mild 79/1.15; Mod 88/1.23 Severe >90/1.33
Goldberg et al., 2009 [21]n = 1957
Age 59–70 yrs
Male 79.4%
DM 26.2%
Retrospective∆SCr (μmol/L):
Mild (26.5–44.2),
Mod-Severe (>44.2)
Mild 8.0 Mod-Severe 7.1Prior AMI 20.9%Adj-HR mortality: Mild transient 1.2; Mild persistent 1.8; Mod-severe transient 1.7; Mod-severe persistent 2.4
Mielniczuk et al., 2009 [22]n = 3795RetrospectiveSCr > 25% over 1-month5Adj-HR 1.6 (95% CI, 1.1–2.3) for composite CV death, recurrent ACS, HF or stroke
Anzai et al., 2010 [23]n = 141
Age 63 yrs
Male 87%
DM 36%
ProspectiveSCr > 26.5 μmol/L within 48 hrs22Anterior STEMIHigher in-hospital death (P =  .004) and major adverse cardiac events (P =  .02)
Marenzi et al., 2010 [24]n = 97
Age 63–69 yrs
Male 69%
DM 18.6%
ProspectiveSCr > 25%55STEMI + IABPIn-hospital death (RR 12.3, 95% CI, 1.8–84.9, P <  .001). AKI associated with age > 75 yrs, LVEF < 40%, mechanical ventilation.

WRF: worsening renal function; SCr: serum creatinine; wks: weeks; m: months; CKD: chronic kidney disease; ESKD: end-stage kidney disease.